Assessment of left ventricular diastolic function plays a major role in the diagnosis and prognosis of cardiac diseases, including heart failure with preserved ejection fraction. We aimed to develop an artificial intelligence (AI)-enabled electrocardiogram…
Continue Reading
Parkinson’s disease (PD) exhibits significant clinical heterogeneity, presenting challenges in the identification of reliable electroencephalogram (EEG) biomarkers. Machine learning techniques have been integrated with resting-state EEG for PD diagnosis, but their practicality is constrained…
Continue Reading
Background: Among the millions of mobile apps in existence, thousands fall under the category of mobile health (mHealth). Although the utility of mHealth apps has been demonstrated for disease diagnosis, treatment data management, and…
Continue Reading
Chaim Linhart, Chaim, Co-founder and CTO at Ibex Medical Analytics
Artificial intelligence (AI) technology is set to transform the field of diagnostics, similar to how X-rays and genetic tests revolutionized healthcare in the past. Reshaping…
Continue Reading
Panel biomarker testing can unlock some of the mysteries of treating patients so that they experience fewer side effects, better quality of life, longer survival rates and potentially, lower costs. At least 22 states…
Continue Reading
Britton Burton Sr. Director of TPRM Strategy
Morgan Hague, Manager of IT Risk Management at Meditology Services
Leaps in healthcare technology continue to benefit humankind: from the advent of the X-ray in the 19th century to…
Continue Reading
Quibim, a trailblazer in Precision Medicine, has unveiled QP-Brain, an AI-driven software revolutionizing early-stage neurodegenerative disease identification. Acquiring regulatory clearance in the US, EU, and UK, this innovation signifies a pivotal advancement. QP-Brain’s precision…
Continue Reading
What You Should Know:
– Intelligent Scopes Corp, a subsidiary of Claritas HealthTech Ltd., and Mayo Clinic have joined forces to develop cutting-edge artificial intelligence (AI) solutions for bladder cancer diagnosis and treatment.
– The goal…
Continue Reading
What You Should Know
– As Americans set their sights on a healthier 2024, a new survey by DrFirst’s iPrescribe app reveals some interesting trends in health priorities and concerns.
– While traditional resolutions like exercising…
Continue Reading
Advancements in AI-driven healthcare and pharmaceuticals are reshaping the industry, evident through recent funding and collaborations. Peptris Technologies, backed by $1 million, expands AI drug discovery to rare diseases. Cipla boosts its stake in…
Continue Reading
